Published in Blood on September 01, 1993
Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol (1997) 0.89
Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice. J Clin Invest (2000) 0.81
Identification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins? PLoS One (2013) 0.78
Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor. PLoS One (2014) 0.75
Factor XI activation in a revised model of blood coagulation. Science (1991) 2.87
Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem (1988) 2.09
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature (1989) 2.07
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood (1997) 1.94
The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem (1980) 1.89
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood (1988) 1.72
Purification and properties of human coagulation factor VII. J Biol Chem (1980) 1.61
Binding of human factor VII and VIIa to monocytes. J Clin Invest (1982) 1.60
Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science (1990) 1.56
Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci U S A (1998) 1.55
Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood (1996) 1.50
A murine model of factor XI deficiency. Blood Coagul Fibrinolysis (1997) 1.49
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem (1998) 1.46
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood (1992) 1.46
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem (1989) 1.45
Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43
The protein Z-dependent protease inhibitor is a serpin. Biochemistry (1999) 1.41
Characterization of the protein Z-dependent protease inhibitor. Blood (2000) 1.41
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood (1996) 1.39
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res (1989) 1.37
Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost (2001) 1.36
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation (2001) 1.35
A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost (2001) 1.33
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood (2001) 1.30
Human Protein Z. J Clin Invest (1984) 1.28
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem (1993) 1.23
The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood (1992) 1.22
Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A (2000) 1.21
Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood (1991) 1.17
Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A (1997) 1.17
Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis (1989) 1.15
Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem (1990) 1.11
Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood (1987) 1.11
Characterization of the inhibition of tissue factor in serum. Blood (1987) 1.10
Comparison of cell-surface TFPIalpha and beta. J Thromb Haemost (2005) 1.09
Purification of human brain tissue factor. J Biol Chem (1985) 1.08
Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrinolysis (1993) 1.08
The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (1994) 1.08
Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A (1987) 1.02
Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost (2004) 1.01
Human coagulation factor Va is a cofactor for the activation of protein C. Proc Natl Acad Sci U S A (1983) 0.99
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A (1990) 0.98
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res (1999) 0.98
Isolation of an extracellular proteinase (keratinase) from Microsporum canis. Sabouraudia (1982) 0.98
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. J Clin Invest (1999) 0.95
Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients. J Thromb Haemost (2009) 0.95
The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood (1984) 0.94
Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo. J Biol Chem (1995) 0.93
The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin. J Biol Chem (1983) 0.93
The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. J Clin Invest (1995) 0.93
Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Blood (1993) 0.93
Endoscopic sphincterotomy for stenosis of the sphincter of Oddi. Surg Endosc (2001) 0.92
Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis (1993) 0.91
Staphylococcal exfoliative toxin induces caseinolytic activity. J Infect Dis (1987) 0.90
The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha. J Biol Chem (1992) 0.90
Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood (1990) 0.89
Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest (1985) 0.89
The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va. J Thromb Haemost (2012) 0.89
[The effect of keratinase on human epidermis, especially on stratum corneum (author's transl)]. Nihon Hifuka Gakkai Zasshi (1981) 0.88
Evolution of human von Willebrand factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand antigen II. Biochem Biophys Res Commun (1987) 0.88
[Isolation, purification and biochemical properties of keratinase elaborated from Microsporum gypseum (author's transl)]. Nihon Hifuka Gakkai Zasshi (1977) 0.88
Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost (2003) 0.86
Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J (1997) 0.86
Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost (2006) 0.86
Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. J Biol Chem (1991) 0.85
Immunological studies of an extra-cellular keratinase. J Dermatol (1983) 0.83
Evidence of clinically significant extravascular stores of factor IX. J Thromb Haemost (2013) 0.83
Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes. J Biol Chem (1997) 0.83
Tissue factor pathway inhibitor. Methods Enzymol (1993) 0.82
Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Arterioscler Thromb Vasc Biol (1999) 0.81
Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science (1990) 0.81
Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem (1996) 0.81
Purification and characterization of bleomycin hydrolase, which represents a new family of cysteine proteases, from rat skin. J Biochem (1996) 0.81
Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2. Biochem J (1990) 0.79
The low density lipoprotein receptor-related protein can function independently from heparan sulfate proteoglycans in tissue factor pathway inhibitor endocytosis. J Biol Chem (1996) 0.79
Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apolipoprotein A-II. Blood (1989) 0.79
Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor. Blood (1990) 0.79
Mouse protein Z-dependent protease inhibitor cDNA. Thromb Haemost (2001) 0.78
Revised DNA sequence of exon 1 and 5' flanking region of the human tissue factor pathway inhibitor gene. Thromb Res (1993) 0.78
Characterization of platelet-releasable forms of beta-amyloid precursor proteins: the effect of thrombin. Blood (1992) 0.78
Factor XI activation by thrombin and factor XIa. Semin Thromb Hemost (1993) 0.78
The current status of coagulation. Ann Med (1995) 0.77
Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery. Thromb Haemost (1991) 0.77
Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo. Blood (2000) 0.77
Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin. Arch Dermatol Res (1999) 0.77
Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response. J Thromb Haemost (2013) 0.77
High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome. J Thromb Haemost (2003) 0.76
Tissue factor pathway inhibitor endocytosis. Trends Cardiovasc Med (1997) 0.76
Low-molecular-weight proteinase inhibitor of human epidermis inhibiting papain and trypsin activity. Arch Dermatol Res (1986) 0.75
The interaction between LACI and heparin. Adv Exp Med Biol (1992) 0.75
Protein Z and protein Z-dependent protease inhibitor and renal tubules. Thromb Haemost (2009) 0.75
cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. Nucleic Acids Res (1990) 0.75
Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains. Biochem J (1994) 0.75
[Case of acute fatty liver of pregnancy with successful salvation of both the mother and the infant]. Nihon Naika Gakkai Zasshi (1994) 0.75
cDNA sequence of rabbit tissue factor pathway inhibitor. Nucleic Acids Res (1992) 0.75